Decreased activity of peptide-elongation factors after treatment with cholesterol esterase

Biochem J. 1978 Apr 15;172(1):9-13. doi: 10.1042/bj1720009.

Abstract

1. Peptide-elongation factors were purified from rat liver and treated with cholesterol esterase and phospholipase A2 immobilized on Sepharose 4B. 2. Binding of L-[3H]-phenylalanyl-tRNA to 40S ribosomal subunits was decreased by approx. 70% and to polyribosomes by 30% in the presence of the binding factor incubated with cholesterol esterase. Treatment of this factor with immobilized phospholipase A2 decreased the binding to smaller ribosomal subunits by only about 15%. 3. Poly(U)-dependent phenylalanine polymerization by ribosomal subunits was decreased to approx. 30% of its original value by treatment of both elongation factors with cholesterol esterase. 4. The normal activity of esterase-treated elongation factor in both the binding reaction and peptide-elongation assay was fully recovered by the addition of cholesteryl 14-methyl-hexadecanoate. 5. Different classes of lipids present in peptide-elongation factor 1 have apparently different functions. Whereas phospholipids are required to maintain the strcture of heavy aggregates of this factor, the presence of cholesteryl 14-methylhexadecanoate is obviously necessary for the normal function of peptide-elongation factors.

MeSH terms

  • Animals
  • Carboxylic Ester Hydrolases / pharmacology*
  • Cholesterol Esters / metabolism
  • Cholesterol Esters / pharmacology
  • Female
  • In Vitro Techniques
  • Liver / metabolism
  • Male
  • Peptide Chain Elongation, Translational / drug effects
  • Peptide Elongation Factors*
  • Phospholipases / pharmacology
  • RNA, Transfer, Amino Acyl / metabolism
  • Rats
  • Ribosomes / metabolism
  • Sterol Esterase / pharmacology*

Substances

  • Cholesterol Esters
  • Peptide Elongation Factors
  • RNA, Transfer, Amino Acyl
  • carcinolipin
  • Phospholipases
  • Carboxylic Ester Hydrolases
  • Sterol Esterase